The MJ Companies|
Byron Shultz joined the MJ team in 2011 as an employee benefits and risk management consultant. He quickly established himself as one of the agency’s top performers and was subsequently promoted to vice president of sales + strategy for the benefits consulting team in Arizona. In addition, he has been appointed as a principal of the firm. From risk management to employee benefits, Byron and his team work collaboratively to develop innovative strategies and create customized solutions tailored to client’s specific needs.
Byron’s strong finance background has enabled him to align key financial business metrics with a company’s risk management and employee benefit programs. He firmly believes in the power of data to drive strategy and identify the most effective and efficient ways to transfer, mitigate, and prevent risk for his clients. His expertise in this area has been instrumental in helping his clients achieve their business goals and objectives.
Related Blogs
2025 Ended with Softest Market Conditions Since 2017 for all Account Sizes & Majority of Lines of Business, The Council’s P/C Market Survey Shows
The MJ CompaniesThe market appeared to move further into the soft part of the insurance market cycle in Q4 2025. Premiums across all account sizes rose ...
Read More
Miles for Miles Helps People With Intellectual and Developmental Disabilities Thrive
Britni ShroutMiles Peck loves school as much for the chance to spend time with his friends as for the classroom experience. He is bracing his ...
Read More
EBSA Updates National Employee Benefit Plan Enforcement Projects for 2026
DeAnn DeckThe Employee Benefits Security Administration (EBSA) announced updates to its national enforcement projects for fiscal year 2026. According to EBSA, these projects highlight areas ...
Read More
The Hard Market Is Shifting—Here’s What That Means for YOU
Adam AdlerFor years, organizations have been told the same thing at renewal: higher costs, fewer options, and little room to negotiate. Now, that message is ...
Read More
Employer Response to Pharma Shifts
Chris AntypasVolatility in the pharmaceutical industry, including the expanding specialty drug pipeline, increased utilization of GLP-1 medications, and persistent supply chain disruptions, are contributing to rising costs ...
Read More
White House Launches TrumpRx, Unveils Drug Prices
DeAnn DeckOn Feb. 5, President Donald Trump announced the launch of TrumpRx.gov, a federally operated website to help individuals buy prescription medications at discounted cash ...
Read More